Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6290997

NCCCC[C@@H](NC(=O)CCc1cccc(O)c1)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@H](CCCCN)NC(=O)CCc3cccc(O)c3)cc2)c2ccc(NC(=O)[C@@H](CCCCN)NC(=O)CCc3cccc(O)c3)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 1/20 0.47
CHRNA1 P02708 3/20 0.42
CHRNG P07510 3/20 0.42
CHRNB1 P11230 3/20 0.42
CHRND Q07001 3/20 0.42
GRIA1 P42261 1/20 0.41
SIRT5 Q9NXA8 4/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP10 P09238 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
MMP14 P50281 1/20 0.41
PLG P00747 1/20 0.40
LTA4H P09960 1/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
SIRT2 Q8IXJ6 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6286503 0.90 CALCRL (0.47) CALCRLCHRNA1CHRNGCHRNB1CHRND
Trifluoroacetic Acid SCHEMBL6286376 0.85 CALCRL (0.46) CALCRLGRIA1SIRT5MMP3PLG
Trifluoroacetic Acid SCHEMBL6282751 0.85 HPGDS (0.48) SIRT5PLG
Trifluoroacetic Acid SCHEMBL6286278 0.84 CALCRL (0.47) CALCRLCHRNA1CHRNGCHRNB1CHRND
Trifluoroacetic Acid SCHEMBL6288016 0.84 CALCRL (0.47) CALCRLCHRNA1CHRNGCHRNB1CHRND
Hydrochloric Acid SCHEMBL6286631 0.83 CHRNA1 (0.51) CALCRLCHRNA1CHRNGCHRNB1CHRND
Hydrochloric Acid SCHEMBL6287855 0.80 CALCRL (0.50) CALCRLPLGLTA4H
Trifluoroacetic Acid SCHEMBL6286184 0.79 ANPEP (0.41) CALCRLCHRNA1CHRNGCHRNB1CHRND
Trifluoroacetic Acid SCHEMBL6290412 0.79 FNTA (0.42) PLG
Trifluoroacetic Acid SCHEMBL6290420 0.79 FNTA (0.42) PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK CALCRL 464/4885CHRNA1 3918/4885CHRNG 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.